E.V. Sibirskaya (1, 2), G.M. Turgunova (2)1) Department of Reproductive Medicine and Surgery FAPE, А.I. Yevdokimov MSUMD, Moscow, Russia; 2) Morozov Children’s City Clinical Hospital, Moscow, Russia
Background. Vulvovaginitis (VV) ranks first in the structure of gynecological diseases of girls and adolescents. This is primarily due to the anatomical features of the structure of children’s genital organs; in addition, alkaline reaction of vaginal secretion, low glycogen content, the absence of Doderlein bacilli, low estrogen level and low immune resistance contribute to the penetration of pathogenic causative agents, leading to the VV occurrence. Description of the clinical case. A clinical case of VV in a 3-year-old girl is described. A local anti-inflammatory therapy with the drug benzydamine (Tantum® Rosa) was carried out 2 times a day for 7 days. Conclusion. Based on the results of the child’s treatment, it has been shown that Tantum® Rosa is one of the effective drugs for treating girls with VV caused by coliform bacteria and streptococci, as well as Candida fungi. The use of this drug in girls and adolescents is recommended in both outpatient and home settings in accordance with the instructions under the supervision of a specialist.
For citations: Sibirskaya E.V., Turgunova G.M. Features of the evaluation of the clinical efficacy of treatment of vulvovaginitis in girls (clinical case). Farmateka. 2019; 26(1):103–107. (in Russian). DOI: https://dx.doi.org/10.18565/pharmateca.2019.1.103-107
Corresponding author: Elena V. Sibirskaya, MD, Chief specialist gynecologist of children and youth in Moscow, obstetrician-gynecologist of the highest qualification category, prof. at the Department of Reproductive Medicine and Surgery A.I. Evdokimov MSMSU, Head at the Department of Gynecology, Morozov Children’s City Clinical Hospital, Moscow, Russia
Address: 1/9, 4th Dobryninsky lane, Moscow 119049, Russia